ROR2 and neoplasm: In the present study, we describe the de novo discovery of fully human antibodies and potent ADCs derived thereof targeting the highly tumor selectively expressed human ROR2, using the Transpo-mAb Display (36) of immune antibody libraries isolated from immunized transgenic mice harboring transgenic IgH and IgL gene loci with human V, D, and J gene segments.